Phase II Study of Enzalutamide for Patients With Androgen Receptor–Positive Salivary Gland Cancers (Alliance A091404)
- Citation:
- J Clin Oncol vol 40 (36) 4240-9
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 12
- Parents:
- 3082
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Astellas
- Grants:
- U10CA180821, U10CA180882, U24 CA196171; UG1CA233160, UG1CA233290, UG1CA233339, P30 CA008748, R01 DE027738 01, U10CA180868 (NRG); U10CA180888 (SWOG);
- Corr. Author:
- Authors:
- Alan L. Ho Nathan R. Foster Alex J. Zoroufy Jordan D. Campbell Francis Worden Katharine Price Douglas Adkins Daniel W. Bowles Hyunseok Kang Barbara Burtness Eric Sherman Roscoe Morton Luc G.T. Morris Zaineb Nadeem Nora Katabi Pamela Munster Gary K. Schwartz
- Networks:
- CA136, COLUMBIA, IWORC, LAPS-CO070, LAPS-CT018, LAPS-MN026, LAPS-MO011, LAPS-NY016, MI014
- Study
- Alliance-A091404
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: